Literature DB >> 12095039

Rejection profile of recent pediatric renal transplant recipients compared with historical controls: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

R McDonald1, P L Ho, D M Stablein, A Tejani.   

Abstract

Historically, higher acute rejection rates, earlier first rejection, and an inability to reverse the rejection characterize pediatric renal transplantation. In recent years, short-term (1-year) graft survival of pediatric renal transplants has steadily improved. To test the hypothesis that these improvements were mediated by changes in acute rejection, we considered the rejection profile of patients who received a renal allograft between 1987 and 1989 (cohort A) and compared it with recipients transplanted between 1997 and 1999 (Cohort B). Cohort A comprised 1469 transplants and cohort B comprised 1189 transplants. Restricting the data to the first year of follow-up, rejection ratios were 1.6 and 0.7, respectively (p < 0.001). Sixty per cent of the later cohort (B) were rejection free at 1 year, compared with 29% for the earlier cohort (A) (p < 0.001). Controlling for donor source, the rejection reversal rate for the later cohort was significantly better than that of the early cohort (p < 0.001). Cumulative distribution of times to first rejection was significantly better for cohort B (p < 0.001). One-year graft survival for cohort B at 94% was significantly better than 80% for cohort A (p < 0.001). We conclude that the improved short-term graft survival is mediated by improvements in the rejection profile in more recently transplanted patients and that this may translate into a better half-life for pediatric renal transplant recipients who received an allograft in the years 1997-99.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12095039     DOI: 10.1034/j.1600-6143.2001.010111.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  5 in total

1.  Renal transplantation: the present and the future.

Authors:  Vikas R Dharnidharka
Journal:  Indian J Pediatr       Date:  2005-09       Impact factor: 1.967

2.  Inferior allograft outcomes in adolescent recipients of renal transplants from ideal deceased donors.

Authors:  Matthew H Levine; Peter P Reese; Alexander Wood; Jorge H Baluarte; Ari Huverserian; Ali Naji; Peter L Abt
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

3.  Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy.

Authors:  Asher D Schachter; Mark R Benfield; Robert J Wyatt; Paul C Grimm; Robert S Fennell; John T Herrin; David S Lirenman; Ruth A McDonald; Ricardo Munoz-Arizpe; William E Harmon
Journal:  Pediatr Transplant       Date:  2006-12

Review 4.  Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.

Authors:  Agnieszka Swiatecka-Urban
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

5.  Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol.

Authors:  Asher D Schachter; K E Meyers; L D Spaneas; J A Palmer; M Salmanullah; J Baluarte; K L Brayman; W E Harmon
Journal:  Pediatr Transplant       Date:  2004-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.